- Q1 2024 Cellectar Biosciences Inc Earnings Call TranscriptMay 14, 2024$3.18 (+3.92%)Earnings
- Q4 2023 Cellectar Biosciences Inc Earnings Call TranscriptMar 27, 2024$3.64 (-5.58%)Earnings
- Cellectar Biosciences Inc KOL Call TranscriptJan 19, 2024
- Cellectar Biosciences Inc at EBD Group Biotech Showcase TranscriptJan 09, 2024
- Cellectar Biosciences Inc Top-line Data Call TranscriptJan 08, 2024
- Q3 2023 Cellectar Biosciences Inc Earnings Call TranscriptNov 02, 2023$2.4 (+0.84%)Earnings
- Cellectar Biosciences Inc Annual Shareholders Meeting TranscriptJun 23, 2023
- Cellectar Biosciences Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 14, 2023
- Cellectar Biosciences Inc at ROTH Conference TranscriptMar 13, 2023
- Cellectar Biosciences Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) TranscriptSep 20, 2021
- Cellectar Biosciences Inc at Ladenburg Thalmann Virtual Healthcare Conference TranscriptJul 14, 2021
- Cellectar Biosciences Inc at Next Generation Targeted Cancer Therapies - The Cellectar Story! TranscriptOct 16, 2020
Cellectar Biosciences Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Good morning, and welcome to day two of Oppenheimer's 33rd Annual Healthcare Conference. I'm Jeff Jones, senior analyst here on the biotechnology team, and I wanted to welcome Jim Caruso, CEO of Cellectar Biosciences.
Jim, I will hand it off to you. Why don't you take this away?
All right. Terrific, Jeff, thank you very much. And thank you once again for the opportunity to participate in your conference, always appreciate it.
As you may or may not know, the obligatory forward-looking statement is always present in any presentation. Cellectar Biosciences, for those of you that are unfamiliar with the story, has really focused on the research and development of oncology therapeutics, both rare pediatric as well as adult malignancies.
The foundation of our focus is our phospholipid ether or PLE delivery platform. And we have demonstrated the capacity to deliver a wide variety of classes of oncology therapeutics
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)